EURAS

EUropean network for neurodevelopmental RASopathies

Programm
Horizon Europe & sub-programmes
Laufzeit
48 Monate (June 2023 – May 2027)
Projektförderung
≈ €8 million
Projektpartner
16

Worum es geht

The EURAS project aims to improve the lives of patients with RASopathies, a group of genetic diseases that arise from increased signaling down the RAS cellular transduction pathway. The project seeks to gain a deeper understanding of the underlying disease mechanisms, create a framework for improved diagnosis, and develop effective treatments for neurodevelopmental RASopathies. The project arising from an initiative of dedicated parents of affected children, is designed to provide solutions for their most urgent needs. Through their national organisations, 1,200 families from 13 European countries have pledged their support for the EURAS work. The project will ultimately lead to the identification and implementation of new, less invasive treatments for patients, increase awareness, promote exchange, and provide patients and families with new state-of-the-art knowledge and therapies.

Koordination

Prof. Dr sc. nat. Anna Fejtová

Universitätsklinikum Erlangen

E-Mail senden

Ihre EURICE-Kontakte

Ihr Kontakt
Melanie Haupenthal
Senior Project Manager
E-mail

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

THE COURT betreten